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MATERIALS AND METHODS:
We present a 58-year-old female patient with painful nodular lesions affecting the area of the left thigh. She reported about tension of the skin and photosensitivity. The patient suffers from arterial hypertension, hydronephrosis IV grade of the left kidney and carcinoma of uterine cervix. The patient was admitted at our department for the first time in June 2015 with normal status of cardiovascular and pulmonary systems. Pathological cutaneous changes affected the back of the trunk and were presented by psoriasiform rashes. Cutaneous appendages and mucous membranes were without pathological changes. Peripheral lymph nodes were not pathologically enlarged. There were no deviations from complete blood count and biochemistry. Elevated levels of MPO(pANCA) -1.38 U/ml, antinuclear antibodies (ANA)-134.1 U/ml (normal value up to 1 U/ml), SS-A(Ro) antibodies -233.7 U/ml (normal value up to 7.5 U/ml) and CRP-12.7mg/l were found. Direct immunofluorescence (DIF) from lesional skin revealed granular band of IgG, IgM and C3 along the dermo-epidermal basement membrane. This result corresponds with Lupus erythematosus. Histopathological result from lesion on the back of the patient confirmed the diagnosis Lupus erythematosus. One month therapy with systemic metylprednisolonei.m. in tapering doses from 60 to 20 mg and chloroquine phosphate tablets 3x250 mg per day was conducted without satisfactory effect. Because of the worsening of the disease and appearance of ulcerative lesions on the thighs the patient was readmitted to our Department in July 2015 ( fig.1a, b) . At the time of the second hospitalization the laboratory results showed elevated levels of leucocytes (11.9x10 9 /L), ASAT -51.1 U/L, urea -8.99 mmol/L, Creactive protein-12.7mg/l and positive protein result from urine analysis. From microbiological examination, Escherichia coli was isolated. Serology tests for hepatic markers for HBsAg (0.534), anti-HCV (0.037), Ebstein Bar virus and Borrelia Burgdorferi were negative. Histopathological result revealed pathologic alterations in small-sized dermal vessels consisting of inflammatory infiltrate of leukocytes, red blood cells and fibrin extravasation, neutrophilic inflammation of the vessel wall, with fibrinoid https://doi.org/10.5272/jimab.2019251.2443 necrosis and fragmented neutrophilic nuclei (nuclear "dust") -histological pattern of necrotizing leukocytoclastic vasculitis ( fig. 2a, b, c) . Chest X-ray was without deviations. Ultrasound of the kidneys established hydronephrosis IV grade. After consultation with cardiologist and echocardiography 10mm pericardial effusion and concentric left ventricular hypertrophy were found. Based on the data from the medical history, clinical picture results from the laboratory investigations and the consultations,the diagnosis lupus vasculitis was made. Systemic treatment with chloroquine phosphate tabl. 250mg 3 times daily, methylprednisolone in tapering doses from 60 mg to 20 mg daily and methotrexate 15 mg. weekly p.o. was administrated for one month.Maintainance therapy with chloroquine phosphate 250mg daily and Methotrexate 15 mg. weekly was conducted. Two-months vacuum therapy course was performed, and the result was complete epithelization of the lesions with atrophic scars (fig. 3a, b) . Fig. 3. a, b . Postlesional atrophic scars on the dorsal-lateral (a) and dorsal surface (b) of the left thigh -after the treatment DISCUSSION: SCLE was first described by Sontheimer et al. in 1979 [2] . Gilliam and Sontheimercreated a classification that divided Lupus erythematosus into specific and nonspecific forms. Specific forms include chronic, subacute and acute cutaneous lupus erythematosus. The non-specific forms comprise leukocytoclastic vasculitis, livedo racemosa, thrombophlebitis, occlusive vasculopathy, Raynaud's syndrome, periungual telangiectasia, diffuse noncicatricial alopecia, erythema multiforme, calcinosis cutis and papular mucinosis [3] .
The combination of SCLE with histological vascular changes is rarely observed [1] . The most common nonspecific findings affect mainly small-sized blood vessels in the dermis. The histopathological picture corresponds to leukocytoclastic vasculitis and is presented by perivascular neutrophilic infiltration, edema and fibrinoid necrosis in the walls of the vessels. The same changes have been described in the patient observed by us. According to the immunological studies elevated ANA values have been reported in the majority of patients with SCLE. There are also increased anti-Ro antibodies and elevated levels of antiLa antibodies [5, 6] . The immunological results of our patient support the diagnosis SCLE. Purpura, erythema, urticaria, nodules and necrosis on the trunk, palmoplantar areas and lower extremities have been described in patients with SCLE in combination with vasculitis. This clinical picture was observed in the case described by us.
Vascular lesions may precede SCLE, but more commonly vasculitis develops in patients with prolonged SCLE [7] . According to a histopathological study by Cribier et al. that the degree of vascular necrosis and the depth of vascular changes were not severe in patients with systemic complications such as glomerulonephritis and gastrointestinal involvement [8] .
The systemic antimalarial drugs such as hydroxychloroquine, chloroquine and mepakine are the most commonly used. Hydroxychloroquine is best tolerated, and therefore it is administered as first-line medication in the treatment of SCLE. Its therapeutic effect could be seen 6 weeks after the first dose [9] .
Systemic corticosteroids and immunosuppressive agents are also used in patients suffering from SCLE. Azathioprine and cyclophosphamide have been reported as effective in the treatment of SCLE in small groups of patients. Thalidomide has been used in severe course of the disease. Improvement is fast, although there are frequent recidives. [10, 11] . Vacuum therapy was reported as an effective method for treatment of refractory for systemic therapy ulcers [12] .
CONCLUSION:
We presented a clinical case of 58-year-old woman diagnosed with lupus vasculitis, treated with chloroquine phosphate, methotrexate and vacuum therapy, with good result. There was complete epithelization of the ulcerative lesions with atrophic scars without new vascular changes. The patient is monitored regularly for systemic manifestations of lupus erythematosus and is under observation by cardiologist, rheumatologist and ophthalmologist. There are no side effects from the systemic treatment so far.
